TABLE 1.
Published developmental toxicity of compounds evaluated in zebrafish.
| Time | Laboratory | Zebrafish lines | Exposure period | Evaluation index | Predictability/test compounds | Notes |
| 2011 | OECD | – | Newly fertilized eggs were exposed for 96 h | Coefficients of variation, LC50 | –/7 | Experiments were evaluated in 7 laboratories |
| 2012 | OECD | – | Newly fertilized eggs were exposed for 96 h | Coefficients of variation, LC50 | –/13 | Experiments were evaluated in 4 laboratories |
| 2012 | AstraZeneca et al. | Wild type and WIK strain | 6 hpf-5 dpf | Morphological scoring, LC25, LOAEL, NOAEL | 60–70%/20 | Experiments were evaluated blinded in 4 laboratories |
| 2012 | FITR* | Wild type | 2 hpf-6 dpf | TI(= LC50//EC50) | 50–60%/27 | Experiments were conducted for 3 times |
| 2012 | Phylonix, Cambridge et al. | – | 6 hpf-5 dpf | TI(= LC50//EC50) | 92%/12 | – |
| 2014 | AstraZeneca et al. | Wild type | 6 hpf-5 dpf | Morphological scoring, LOAEL, TI(= LC25/NOAEL) | 62–82%/38 | Experiments were evaluated blinded in 2 laboratories |
| 2014 | FDA | Hb9: GFP transgenic zebrafish | 24 hpf-52 hpf | Body length, fiber length | –/5 | – |
*Flemish Institute for Technological Research.